[1]
BRODT-LEMES, M.L. , BRUSCATO, D.S. , MADRUGA, D.S. , SMANIOTTO, J. , SAGGIORATO-LUBIAN, J.R. , DE-VILLA, L.T. , CAON, S. and SILVA, T.B. 2024. Budget impact analysis of the incorporating of biosimilars in a cancer institute of a philanthropic hospital. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde. 15, 3 (Sep. 2024), e1130. DOI:https://doi.org/10.30968/rbfhss.2024.153.1130.